ACOTEC-B (06669) announced that on August 22, 2025, the Group received registration approval from China's National Medical Products Administration for its Peripheral Controllable Mechanical Detachment Fibered Coil. This product is designed for the embolization of peripheral vascular aneurysms, arteriovenous malformations, and arteriovenous fistulas. The product features a controllable detachment mechanism that ensures stable and precise coil deployment, enhancing operational controllability and safety. Additionally, the product offers both 2D and 3D structural options to broadly accommodate clinical requirements. The company will conduct marketing activities in China at an appropriate time.